The current rise in COVID-19 cases is not a harbinger of a “new wave” but an “expected fluctuation” during endemic prevalence, experts have said, emphasising that lack of mask-wearing and low intake of booster shots may be reasons behind the surge.

They also said the recent surge is due to increased travel, social gathering and economic activities resulting in a greater possibility of the transmission of the virus.

Seventeen districts in India, including seven from Kerala and five from Mizoram, are reporting a weekly COVID-19 positivity rate of more than 10 percent. In 24 districts, including seven from Kerala and four each from Maharashtra and Mizoram, the weekly positivity is between 5 to 10 per cent, an official source said.

Noted virologist T Jacob John said the present increase in cases is not like a surge but a gradual increase that is not steady or uniformly distributed.

“A few states lead, others are not involved. In those states, the phenomenon is mainly a big city picture, not widely spreading. This pattern is not a harbinger of a new wave but expected fluctuations during endemic prevalence,” he said.

“A wave must have more numbers than the previous day consistently — that is not the case for us now,” he told PTI.

He said not wearing and not taking booster shots can be two main reasons for the surge.

“Who gave the orders that people need not wear masks any longer. Who advised that people should continue wearing masks in places where people assemble indoors? That one behaviour alone is sufficient to explain the gradual increase in cities,” John said.

The second obstacle, he said, is people not taking booster doses.

“The higher the booster dose coverage, the lower will the number of infections; lower the number of infections, lower the number of cases,” he said.

John, a former director of the ICMR’s Centre of Advanced Research in Virology, said less than five per cent of those who had a second dose had taken their boosters.

“Who is responsible for this low coverage? I understand people are not trusting the government regarding vaccine safety — and the government is not bothered either.

”When the threat of epidemic is no longer urging people to opt for a complete immunisation schedule, people will not accept the risk of severe adverse reactions,” he said.

He refuted claims that new variants are responsible for the surge.

“Currently the popular feeling is that BA.5 and BA.4 are causing the increase. On the other hand, when viruses are encouraged to spread, the faster-spreading ones will show up,” he said.

Dr Chandrakant Lahariya, physician-epidemiologist and infectious disease specialist, said India’s situation is of hybrid immunity through natural infection (three national waves) and acquired immunity as nearly 88 per cent of the adult population has received two shots of COVID-19 vaccines.

“Then, Omicron is the predominant variant and even though two new sub-lineage of Omicron, BA.4 and BA.5 have been reported to be slightly more transmissible, those sub-lineage are barely present in India and not enough to fuel a major spike.

“There is no evidence of the emergence of a new variant of concern. Putting all of these together, it is fair to conclude that the current localised surge is not a start of a new national wave,” he said.

To put the surge in context, he said there are two things to remember. “One, neither an earlier SARS CoV2 infection nor the COVID-19 vaccination (at least not the ones which are being used in India) are known to prevent subsequent infection.

“Second, now SARS CoV2 is present in all settings and is likely to stay around for long. Alongside, COVID-19 being an infectious disease, the rise and fall in the cases is going to be a routine process. What we are seeing in select Indian cities and states in terms of a spike in COVID-19 cases is on expected lines,” he told PTI.

A rise may be seen in additional cities and states in months to follow but with every rise “we should not jump to the conclusion that it is a fresh wave”, he said.

Giridhar R. Babu, who also heads Lifecourse Epidemiology at the Indian Institute of Public Health in Bengaluru, sa

Read More